51 Biggest Movers From Yesterday

Gainers

• Krystal Biotech, Inc. KRYS shares surged 121.7% to close at $88.24 on Monday after the company announced positive topline results from the GEM-3 Phase 3 trial of investigational beremagene geperpavec (B-VEC, Vyjuvek) for dystrophic Epidermolysis Bullosa (dystrophic EB).
• Petros Pharmaceuticals, Inc. PTPI climbed 91.4% to close at $4.00 after jumping 14% on Friday. Petros Pharmaceuticals recently said Q3 sales results were down year over year.
• Adagio Therapeutics, Inc. ADGI gained 86.4% to settle at $46.83 after the company said its COVID-19 monoclonal antibody, ADG20, is likely to retain activity against Omicron, as observed in in vitro models with all other variants of concern identified previously. Morgan Stanley upgraded Adagio Therapeutics from Equal-Weight to Overweight and announced a $49 price target.
• Palatin Technologies, Inc. PTN climbed 53.3% to close at $0.8550 after gaining over 8% on Friday. Palatin Technologies recently posted a quarterly loss of $0.03 per share.
• AeroClean Technologies, Inc. AERC gained 44.9% to settle at $117.35. AeroClean Technologies reported closing of initial public offering and partial exercise of over-allotment option.
• cbdMD, Inc. YCBD jumped 30.2% to clsoe at $1.94 on Monday after the company announced a multi-year exclusive agreement with Amify, an Amazon.com platform partner.
• iBio, Inc. IBIO gained 29.2% to close at $0.8537. iBio, earlier during the month, posted a Q1 loss of $0.04 per share, versus from a year-ago loss of $0.05 per share.
• Pioneer Power Solutions, Inc. PPSI gained 27.2% to settle at $7.63.
• Matterport, Inc. MTTR climbed 21.2% to close at $33.05, rebounding after the sector dipped on Friday amid a COVID-driven selloff.
• NRx Pharmaceuticals, Inc. NRXP rose 20% to close at $8.10 after the company announced positive data from its ZYESAMI study.
• Femasys Inc. FEMY climbed 19.2% to settle at $5.41. Femasys, earlier during the month, posted a Q3 loss of $0.19 per share.
• Snow Lake Resources Ltd. LITM surged 17.7% to close at $7.63. The company recently priced its IPO at $7.50 per share.
• iSpecimen Inc. ISPC gained 16.6% to close at $20.42 after jumping around 72% on Friday. The company recently announced a contract to support new advanced research on COVID-19.
• Draganfly Inc. DPRO jumped 16.5% to settle at $2.76.
• Dermata Therapeutics, Inc. DRMA gained 15.9% to close at $3.13.
• KULR Technology Group, Inc. KULR jumped 15.8% to settle at $3.45.
• IO Biotech, Inc. IOBT gained 14.9% to close at $8.74. The company, earlier during the month, priced its IPO at $14 per share.
• Lithium Americas Corp. LAC jumped 14.8% to settle at $40.96.
• Applied DNA Sciences, Inc. APDN gained 14.3% to close at $6.06 after the company announced its COVID-19 diagnostic strategy in response to the emergence of Omicron. The company plans to introduce its Linea 2.0 COVID-19 Assay kit.
• Stran & Company, Inc. STRN rose 13.4% to close at $3.55.
• Valneva SE VALN rose 12.9% to settle at $67.28. Valneva recently signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate VLA2001, over two years.
• Vir Biotechnology, Inc. VIR jumped 12.4% to close at $40.48. The United States government recently signed contracts worth about $1 billion to secure the antibody-based COVID-19 treatment developed by GlaxoSmithKline and Vir Biotechnology.
• Moderna, Inc. MRNA climbed 11.8% to settle at $368.51 amid the Omicron variant of COVID-19. Moderna is confident it will have something on the table shortly to tackle the latest virus threat.
• R. R. Donnelley & Sons Company RRD climbed 10% to close at $10.22 after the company announced it received a $10/share acquisition offer from a strategic buyer.
• Organovo Holdings, Inc. ONVO rose 5.9% to settle at $4.99.
• 180 Life Sciences Corp. ATNF gained 5.6% to close at $5.71 after climbing over 21% on Friday.

Check out these big penny stock gainers and losers

Losers

• Fennec Pharmaceuticals Inc. FENC shares tumbled 50.4% to close at $4.78 on Monday after the company said it expects to receive a Complete Response Letter (CRL) from the FDA regarding its marketing application for Pedmark. The FDA indicated that, following a recent inspection of the manufacturing facility of the drug product manufacturer, deficiencies have been identified.
• MiNK Therapeutics, Inc. INKT dipped 33.6% to settle at $13.28.
• Vaxxinity, Inc. VAXX fell 25.8% to close at $13.70. Vaxxinity, earlier during the month, priced its IPO at $13 per share.
• Xilio Therapeutics, Inc. XLO dipped 23.7% to settle at $15.20.
• Aura Biosciences, Inc. AURA fell 21.5% to close at $17.75. Aura Biosciences recently posted a Q3 loss of $28.33 per share.
• Theseus Pharmaceuticals, Inc. THRX fell 20.8% to close at $14.49. Theseus Pharmaceuticals recently reported quarterly losses of $5.16 per share.
• Aptevo Therapeutics Inc. APVO fell 19.4% to settle at $10.53.
• Armata Pharmaceuticals Inc. ARMP dropped 17.6% to close at $4.30.
• La Jolla Pharmaceutical Company LJPC fell 17.2% to settle at $3.89. La Jolla Pharma recently reported a $10 million buyback plan.
• LianBio LIAN dipped 16.1% to settle at $13.43 on Monday.
• Allied Healthcare Products, Inc. AHPI fell 15.9% to close at $7.00 after jumping around 55% on Friday.
• Huadi International Group Co., Ltd. HUDI dropped 15.3% to settle at $16.48.
• Longeveron Inc. LGVN fell 14.4% to close at $26.25.
• Progenity, Inc. PROG dipped 14.3% to close at $3.12.
• Sonendo, Inc. SONX fell 14.1% to settle at $9.88. The company, last month, priced its IPO at $12 per share.
• TOMI Environmental Solutions, Inc. TOMZ fell 13.4% to close at $1.16 after climbing over 15% on Friday. TOMI Environmental Solutions recentlyeported a third-quarter net sales decline of 48.6% year-over-year to $2.2 million and grew 50% sequentially.
• Local Bounti Corporation LOCL fell 11.9% to close at $9.00.
• Altisource Portfolio Solutions S.A. ASPS fell 11.5% to close at $10.62.
• NeuroPace, Inc. NPCE dipped 11.4% to close at $10.48. Neuropace recently announced that it has received an investigational device exemption from the U.S. Food and Drug Administration to study its proprietary RNS System in patients with drug-resistant idiopathic generalized epilepsy.
• The Beachbody Company, Inc. BODY fell 10.6% to close at $2.62. Loop Capital analyst Daniel Adam recently downgraded Beachbody Company to Sell from Hold with a price target of $2, down from $9, implying a 35% downside.
• Biofrontera Inc. BFRI fell 10.1% to close at $7.10. Biofrontera priced its 2,857,143 private placement at $5.25 per share.
• AgriFORCE Growing Systems, Ltd. AGRI fell 10% to close at $2.15.
• GeoVax Labs, Inc. GOVX fell 9.2% to settle at $4.26. GeoVax recently highlighted presentation of COVID-19 vaccine data at Vaccine World Asia Congress.
• Zevia PBC ZVIA fell 6.4% to close at $7.47.
• Wejo Group Limited WEJO fell 5.8% to close at $7.00.